Literature DB >> 14649732

High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU.

Sankar Surendran1, Gerald A Campbell, Stephen K Tyring, Kimberlee Matalon, J David McDonald, Reuben Matalon.   

Abstract

Phenylketonuria (PKU) is a metabolic disorder caused by phenylalanine hydroxylase deficiency leading to increased levels of phenylalanine in the brain. Hyperactivity is reportedly induced by a high level of orexin A, and therefore orexin A content was studied in the PKU mice. Hypothalamus and brain stem had higher levels of orexin A compared to cerebrum and cerebellum both in wild type and PKU mice brains as observed by radioimmunoassay method. Interestingly, all these regions of the brain in PKU mouse showed a higher level of orexin A compared to the wild type. Heart and plasma also had higher levels of orexin A in PKU compared to the wild type. Immunohistochemical analysis revealed an increased number of orexin A-stained cells in the brain and heart of PKU mouse compared to the wild type. This is the first report of increased level of orexin in the PKU mouse brain. Hyperactivity is commonly observed in children with PKU; thus these findings suggest that orexin A is a contributing factor for the hyperactivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14649732     DOI: 10.1023/a:1026184127689

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

1.  Cardiovascular regulatory actions of the hypocretins in brain.

Authors:  W K Samson; B Gosnell; J K Chang; Z T Resch; T C Murphy
Journal:  Brain Res       Date:  1999-06-12       Impact factor: 3.252

2.  Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations.

Authors:  B Rouse; L Lockhart; R Matalon; C Azen; R Koch; W Hanley; H Levy; F dela Cruz; E Friedman
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Cardiovascular defects among the progeny of mouse phenylketonuria females.

Authors:  J D McDonald; C A Dyer; L Gailis; M L Kirby
Journal:  Pediatr Res       Date:  1997-07       Impact factor: 3.756

4.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Authors:  T Sakurai; A Amemiya; M Ishii; I Matsuzaki; R M Chemelli; H Tanaka; S C Williams; J A Richardson; G P Kozlowski; S Wilson; J R Arch; R E Buckingham; A C Haynes; S A Carr; R S Annan; D E McNulty; W S Liu; J A Terrett; N A Elshourbagy; D J Bergsma; M Yanagisawa
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

5.  Distribution of orexin neurons in the adult rat brain.

Authors:  T Nambu; T Sakurai; K Mizukami; Y Hosoya; M Yanagisawa; K Goto
Journal:  Brain Res       Date:  1999-05-08       Impact factor: 3.252

6.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

7.  Effects of restricted feeding on the activity of hypothalamic Orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats.

Authors:  Tatsuhiko Kurose; Yoichi Ueta; Yukiyo Yamamoto; Ryota Serino; Yumi Ozaki; Jun Saito; Shoji Nagata; Hiroshi Yamashita
Journal:  Regul Pept       Date:  2002-03-15

Review 8.  Cardiovascular effects of leptin and orexins.

Authors:  Tetsuro Shirasaka; Mayumi Takasaki; Hiroshi Kannan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-03       Impact factor: 3.619

9.  The natural history of untreated phenylketonuria over 20 years.

Authors:  D B Pitt; D M Danks
Journal:  J Paediatr Child Health       Date:  1991-06       Impact factor: 1.954

10.  Phenylketonuria and some aspects of emotional development.

Authors:  M M Hendrikx; L W van der Schot; F M Slijper; J Huisman; A F Kalverboer
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

View more
  2 in total

1.  Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.

Authors:  Patrick Solverson; Sangita G Murali; Adam S Brinkman; David W Nelson; Murray K Clayton; Chi-Liang Eric Yen; Denise M Ney
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-31       Impact factor: 4.310

2.  Sleep Disturbances in Phenylketonuria: An Explorative Study in Men and Mice.

Authors:  Vibeke M Bruinenberg; Marijke C M Gordijn; Anita MacDonald; Francjan J van Spronsen; Eddy A Van der Zee
Journal:  Front Neurol       Date:  2017-04-26       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.